.Merck defeats revenues desires, increases purchases outlook on sturdy requirement for top medicines like Keytruda CNBCMerck & Co. (MRK US) Beats Income Projections as Keytruda Sales Surge BloombergMerck Inventory: Pharma Giant Posts Powerful End Results, However Outlook Falls Short Capitalist's Organization DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck beats income and also purchases requirements amid Keytruda strong point, however gives blended full-year expectation MarketWatch.